Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleORIGINAL ARTICLES
Open Access

Schizophrenia relapse in relation to drug treatment

Abdulrazzak M. Alhamad
Neurosciences Journal January 2005, 10 (1) 68-72;
Abdulrazzak M. Alhamad
Division of Psychiatry, College of Medicine, King Saud University, PO Box 7805, Riyadh 11472, Kingdom of Saudi Arabia. Tel. +966 (1) 4672362. Fax. +966 (1) 4672571. E-mail: [email protected]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE: To assess and compare, prospectively, schizophrenia relapse in relation to neuroleptic medication in long term maintenance therapy.

METHODS: All schizophrenic patients who met the DSM-IV criteria attending King Khalid University Hospital psychiatry outpatient clinic, Riyadh, Kingdom of Saudi Arabia in January 1994, and who fulfilled the inclusion criteria of the study, were assessed at baseline using the brief psychiatric rating scale (BPRS), quality of life scale and the extrapyramidal rating scale, and at each relapse and 6 weeks after treatment of the relapse and followed for 10 years after being allocated to one of 3 groups of neuroleptic medications depot (group A), conventional (group B) and atypical, clozapine (group C). A data collection form including sociodemographic data and other clinical indices was also completed for the patients.

RESULTS: Seventy-six schizophrenic patients met the DSM-IV diagnostic criteria, but only 59 patients fulfilled the inclusion criteria of the study and 4 patients quit the study. The mean age was 27.45 years and 63.6% were males and 98.2% were Saudis. There was a statistical significance of the BPRS scores before and after relapse for groups A and C, but not for group B. The relapse rates at one year, 2 years, 3 years, and 5 years were in the range 13.3-34.6% for groups A and C but much higher at 35.7-85.7% for group B.

CONCLUSION: Relapse rate in schizophrenia can be markedly reduced by effective maintenance neuroleptic treatments adhered to by the psychiatrist leaving more room for further reduction of relapse by implementing other measures such as lowering the expressed emotion, psychoeducation and rehabilitation. Further long-term large sample research is needed to affirm this.

  • Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

PreviousNext
Back to top

In this issue

Neurosciences Journal: 10 (1)
Neurosciences Journal
Vol. 10, Issue 1
1 Jan 2005
  • Table of Contents
  • Cover (PDF)
  • Index by author
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Schizophrenia relapse in relation to drug treatment
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Schizophrenia relapse in relation to drug treatment
Abdulrazzak M. Alhamad
Neurosciences Journal Jan 2005, 10 (1) 68-72;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Schizophrenia relapse in relation to drug treatment
Abdulrazzak M. Alhamad
Neurosciences Journal Jan 2005, 10 (1) 68-72;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Characteristics of the patients who admitted to the emergency department with seizures and the factors affecting the frequency of admission
  • Prescribing practices in the treatment of depression among psychiatrists in Oman
  • Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
Show more ORIGINAL ARTICLES

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire